Search Results 511-520 of 18582 for alopecia

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder, Telogen ...

2. First In Human Study Of TORL-1-23 In Participants With Advanced Cancer - Mayo Clinic

   ... alopecia or laboratory abnormalities otherwise meeting eligibility requirements * Received prior chemotherapeutic, investigational, or other therapies for ...

3. Skin biopsy - Doctors & Departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Vascular anomaly, Nonmelanoma skin cancer, Tuberous ...

4. Sleep disorders - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Vascular anomaly, Nonmelanoma skin cancer, Tuberous ...

5. A Study To Evaluate Abemaciclib For Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

   Exceptions: Residual alopecia and Grade 2 peripheral neuropathy are allowed. Concurrent use of strong and moderate inducers and/or strong inhibitors of ...

6. Actinic keratosis - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Rosacea, Melasma, Leukoplakia, Age spots, Facial volume loss, Vulvar disorder, Oral ulcerative condition. Show more areas of focus for ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...

8. CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin - Mayo Clinic

   Resolution of treatment-related toxicity to < grade 1; alopecia and cutaneous toxicity are allowed < grade 2; >1 week since palliative RT; Ability to ...

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Scarring alopecia, Tinea versicolor, Rosacea, Melasma, Vitiligo, Vascular malformation, Vascular anomaly, Nonmelanoma skin cancer, Tuberous ...

10. Testing The Addition Of An Anti-cancer Drug, ASTX727, To Chemotherapy (Paclitaxel) And Immunotherapy (Pembrolizumab) For Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    (i.e., have residual toxicities > Grade 1) with the exception of alopecia. - Note: If patients received major surgery, they must have recovered adequately